The expression of CRMP2 in breast cancer was previously investigated by Shimada et al (45), who revealed that the mRNA and protein expression of CRMP2 were significantly decreased in breast cancer tissues compared with that in the normal tissues. This evidence concerns the gene DPYSL2 and breast cancer.